Send feedback

IPO8 p.Ser984=

c.2952C>T · rs746079753 · VCV2498551

Likely benign Single submitter
Classification
Likely benign
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
very rare (popmax 0.00636%, nfe)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
REVEL0.104moderately benign-leaning
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.076phastCons 0.071
Overall
CADD7.38PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00636% European (non-Finnish) · 75/1,179,918 alleles
Filtering AF 0.00519% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00474%
Overall 0.00502% 81/1,612,798 alleles · very rare exomes 74/1,460,672 · genomes 7/152,126 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.00641% 15,611
European (non-Finnish)grpmax 0.00636% 15,732
Admixed American 0.00167% 59,984
South Asian 0.0011% 91,050

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
IPO8
Protein
p.Ser984=
Coding
c.2952C>T
MANE Select
NM_006390
dbSNP
rs746079753
Type
single nucleotide variant
Location
chr12:30631959 (GRCh38)
Gene constraint
LOEUF 0.575 · pLI 0.15 (gnomAD)
Structure
AlphaFold pLDDT 87.59
Residue 984
a UniProt-annotated variant site (in viss; undetectable protein levels in either patient's fibroblasts or patient's epstein-barr virus-immortalized b cell lines); a UniProt-annotated variant site (in viss); a UniProt-annotated variant site (in viss; undetectable protein levels in patient's fibroblasts, although mrna levels seem unaffected)
Full IPO8 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ipo8-p-ser984 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown